“旋切术”作为治疗冠状动脉钙化的最新策略:范围综述

IF 3.4 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Tianxu Hao, Zhenchun Song, Jiechun Li, Rui Suo, Yan Li, Yibei Lu, Ximing Li, Dongxia Jin
{"title":"“旋切术”作为治疗冠状动脉钙化的最新策略:范围综述","authors":"Tianxu Hao,&nbsp;Zhenchun Song,&nbsp;Jiechun Li,&nbsp;Rui Suo,&nbsp;Yan Li,&nbsp;Yibei Lu,&nbsp;Ximing Li,&nbsp;Dongxia Jin","doi":"10.1155/cdr/3713315","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> Recently, the combination of rotational atherectomy (RA) with intravascular lithotripsy (IVL), known as “RotaTripsy,” has been employed in the treatment of coronary lesions with severe calcification. In this article, we provide an overview of the current evidence regarding this technique, emphasizing the importance of appropriate patient and lesion selection to achieve optimal clinical outcomes, including the primary goal of improvement of stenting and enhancement of short and long-term prognosis.</p><p><b>Methods:</b> We performed a systematic literature search using PubMed, Embase, Web of Science, and Cochrane library up to July 2024 for studies that combined RA and IVL for coronary artery calcification lesions that were included. The retrieved articles and references of the primary articles were used to collect the basic information. SPSS 20.0 and Excel statistic software were used to conduct this scoping review.</p><p><b>Results:</b> A total of 25 studies consisting of 259 patients were identified. Of all the patients, 208 (80.3%) were male. Patients had an average age of 68.31 years, and 119 (45.95) patients had acute coronary syndrome. In addition, 218 (84.17%) had hypertension, 128 (49.42%) had diabetes mellitus, and 48 (18.53%) had chronic kidney disease. In the ultimate analysis, 252 patients (97.3%) successfully underwent the “RotaTripsy” procedure, with a minimal mortality rate of only 7 individuals (2.7%) during the follow-up period.</p><p><b>Conclusions:</b> “RotaTripsy,” as an efficacious therapeutic modality, shows its unique potential for severe calcified coronary artery lesions resistant to dilation. Our research findings substantiate its feasibility, safety, and effectiveness in clinic.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/3713315","citationCount":"0","resultStr":"{\"title\":\"“RotaTripsy” as State-of-the-Art Strategy for Coronary Artery Calcification: A Scoping Review\",\"authors\":\"Tianxu Hao,&nbsp;Zhenchun Song,&nbsp;Jiechun Li,&nbsp;Rui Suo,&nbsp;Yan Li,&nbsp;Yibei Lu,&nbsp;Ximing Li,&nbsp;Dongxia Jin\",\"doi\":\"10.1155/cdr/3713315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Background:</b> Recently, the combination of rotational atherectomy (RA) with intravascular lithotripsy (IVL), known as “RotaTripsy,” has been employed in the treatment of coronary lesions with severe calcification. In this article, we provide an overview of the current evidence regarding this technique, emphasizing the importance of appropriate patient and lesion selection to achieve optimal clinical outcomes, including the primary goal of improvement of stenting and enhancement of short and long-term prognosis.</p><p><b>Methods:</b> We performed a systematic literature search using PubMed, Embase, Web of Science, and Cochrane library up to July 2024 for studies that combined RA and IVL for coronary artery calcification lesions that were included. The retrieved articles and references of the primary articles were used to collect the basic information. SPSS 20.0 and Excel statistic software were used to conduct this scoping review.</p><p><b>Results:</b> A total of 25 studies consisting of 259 patients were identified. Of all the patients, 208 (80.3%) were male. Patients had an average age of 68.31 years, and 119 (45.95) patients had acute coronary syndrome. In addition, 218 (84.17%) had hypertension, 128 (49.42%) had diabetes mellitus, and 48 (18.53%) had chronic kidney disease. In the ultimate analysis, 252 patients (97.3%) successfully underwent the “RotaTripsy” procedure, with a minimal mortality rate of only 7 individuals (2.7%) during the follow-up period.</p><p><b>Conclusions:</b> “RotaTripsy,” as an efficacious therapeutic modality, shows its unique potential for severe calcified coronary artery lesions resistant to dilation. Our research findings substantiate its feasibility, safety, and effectiveness in clinic.</p>\",\"PeriodicalId\":9582,\"journal\":{\"name\":\"Cardiovascular Therapeutics\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/3713315\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/cdr/3713315\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/3713315","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:最近,旋转动脉粥样硬化切除术(RA)联合血管内碎石术(IVL),被称为“旋转碎石术”,已被用于治疗严重钙化的冠状动脉病变。在本文中,我们概述了目前关于该技术的证据,强调了适当的患者和病变选择对于获得最佳临床结果的重要性,包括改善支架置入和增强短期和长期预后的主要目标。方法:我们使用PubMed、Embase、Web of Science和Cochrane图书馆进行了系统的文献检索,检索截止到2024年7月,包括RA和IVL联合治疗冠状动脉钙化病变的研究。利用检索到的文献和主要文献的参考文献收集基本信息。采用SPSS 20.0和Excel统计软件进行范围审查。结果:共纳入25项研究,共纳入259例患者。其中男性208例(80.3%)。患者平均年龄68.31岁,急性冠脉综合征119例(45.95例)。此外,高血压218例(84.17%),糖尿病128例(49.42%),慢性肾病48例(18.53%)。在最终分析中,252例患者(97.3%)成功地接受了“RotaTripsy”手术,随访期间死亡率最低的只有7例(2.7%)。结论:“旋切术”作为一种有效的治疗方式,显示出其对难以扩张的严重钙化冠状动脉病变的独特潜力。我们的研究结果证实了该方法的可行性、安全性和临床有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

“RotaTripsy” as State-of-the-Art Strategy for Coronary Artery Calcification: A Scoping Review

“RotaTripsy” as State-of-the-Art Strategy for Coronary Artery Calcification: A Scoping Review

Background: Recently, the combination of rotational atherectomy (RA) with intravascular lithotripsy (IVL), known as “RotaTripsy,” has been employed in the treatment of coronary lesions with severe calcification. In this article, we provide an overview of the current evidence regarding this technique, emphasizing the importance of appropriate patient and lesion selection to achieve optimal clinical outcomes, including the primary goal of improvement of stenting and enhancement of short and long-term prognosis.

Methods: We performed a systematic literature search using PubMed, Embase, Web of Science, and Cochrane library up to July 2024 for studies that combined RA and IVL for coronary artery calcification lesions that were included. The retrieved articles and references of the primary articles were used to collect the basic information. SPSS 20.0 and Excel statistic software were used to conduct this scoping review.

Results: A total of 25 studies consisting of 259 patients were identified. Of all the patients, 208 (80.3%) were male. Patients had an average age of 68.31 years, and 119 (45.95) patients had acute coronary syndrome. In addition, 218 (84.17%) had hypertension, 128 (49.42%) had diabetes mellitus, and 48 (18.53%) had chronic kidney disease. In the ultimate analysis, 252 patients (97.3%) successfully underwent the “RotaTripsy” procedure, with a minimal mortality rate of only 7 individuals (2.7%) during the follow-up period.

Conclusions: “RotaTripsy,” as an efficacious therapeutic modality, shows its unique potential for severe calcified coronary artery lesions resistant to dilation. Our research findings substantiate its feasibility, safety, and effectiveness in clinic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信